NEW YORK, Oct. 16, 2020 — Taglich Brothers, Inc. announces that it has initiated coverage of Global WholeHealth Partners Corp. (OTC: GWHP). Global WholeHealth Partners Corp., headquartered in San Clemente, CA, was founded to develop, manufacture and market in-vitro and rapid diagnostic tests with the long-term goal of being a low cost provider of infectious disease diagnostics based on molecular solutions that lessen the time to diagnose medical results and empowering healthcare professionals to make accurate decisions for patients. The company plans to produce and sell rapid diagnostic tests that include but is not limited to, Corona Viruses including COVID-19, Ebola, ZIKA, Dengue, Malaria, Influenza, and Tuberculosis. The complete 16-page report is available at www.taglichbrothers.com   Taglich Brothers, Inc. is a full-service broker dealer focused exclusively on microcap companies. The Company defines the microcap segment of the equity market as companies with less than $250 million in market capitalization. Taglich Brothers currently offers institutional and retail brokerage services, investment banking and comprehensive research coverage to the investment community. We do not undertake to advise you as to changes in figures or our views. This is not a solicitation of any order to buy or sell. Taglich Brothers, Inc. is fully disclosed with its   Read more…